Scientists discover nucleoli damage could kill cancer cells
(Medical Xpress) -- Damaging a cells nucleolus could destroy cancer cells by increasing levels of the most important tumour prevention protein, p53, reveals research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool, today.
Scientists at The University of Liverpool have discovered that the nucleolus a cell component found inside the nucleus directly regulates the level of a cancer-protector protein called p53. And p53, called the guardian of the genome, blocks tumour development by triggering a stop signal which prevents cells dividing out of control.
The team, whose research was jointly funded by Cancer Research UK, Yorkshire Cancer Research, North West Cancer Research Fund and Mersey Kidney Research, discovered that p53 proteins enter nucleoli to be labelled for destruction. These tagged p53 proteins are then broken up in another part of the cell.
But cell stresses, such as heat, lack of nutrients, high or low salt levels and DNA damage, stop the nucleolus from working. This in turn prevents p53 from being destroyed, so p53 levels automatically increase and stop the cell dividing. Eventually the cell dies.
This suggests that nucleoli are a powerful new target for the development of new cancer drugs.
Dr. Carlos Rubbi, based at the Liverpool Cancer Research UK Centre, the University of Liverpool, presenting the research, said: This research implies that scientists can kill cancer cells by targeting the nucleoli to increase levels of protective p53.
It explains how levels of the most important cancer protector protein, p53, increase in response to such a wide variety of cell stresses.
This potentially means there is a whole range of new drug targets available to us, and suggests that it may not be necessary to use only DNA damage techniques - such as chemotherapy and radiotherapy - to raise levels of p53.
Until now, nucleoli were just thought to be the places where ribosomes protein factories are made. This research shows nucleoli have additional cell control functions and provide the link between the detection of cell stress and the cells response.
Professor Sir David Lane, co-discoverer of p53, said: We discovered p53 the first natural tumour suppressor protein, which protects cells from turning cancerous more than 30 years ago.
But decades later, our team and other scientists are still making incredible discoveries about the behaviour of p53 and the many ways it regulates cells.
Today it is at the heart of new techniques being developed to treat cancer. And this latest finding, that a simple part of the cell could potentially be targeted to increase the levels of p53, is exciting news and has the potential to influence greatly the development of future approaches to destroying cancer cells.
More information: www.ncri.org.uk/nc… 55.html ;
Provided by Cancer Research UK
-
Cancer is a p53 protein aggregation disease
Mar 29, 2011 |
not rated yet |
0
-
Study pinpoints protein's role in cancer spread
Jul 24, 2006 |
not rated yet |
0
-
Guardian of genome predicts treatment outcomes for childhood cancer
Nov 05, 2007 |
not rated yet |
0
-
Effect of mutant p53 stability on tumorigenesis and drug design
May 15, 2008 |
not rated yet |
0
-
Newly discovered gene plays vital role in cancer
Feb 27, 2009 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
How can there be a term called "intestinal metaplasia" of stomach
13 hours ago
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
Small cancer risk following CT scans in childhood and adolescence confirmed
The gap between life expectancy in patients with a mental illness and the general population has widened since 1985 and efforts to reduce this gap should focus on improving physical health, suggest researchers in a paper ...
Cancer
2 hours ago |
not rated yet |
0
Changing cancer's environment to halt its spread
By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...
Cancer
3 hours ago |
not rated yet |
0
Novel RNA-based classification system for colorectal cancer
A novel transcriptome-based classification of colon cancer that improves the current disease stratification based on clinicopathological variables and common DNA markers is presented in a study published in PLOS Medicine this w ...
Cancer
3 hours ago |
not rated yet |
0
Low radiation scans help identify cancer in earliest stages
A study of veterans at high risk for developing lung cancer shows that low-dose computed tomography (LDCT) can be highly effective in helping clinicians spot tiny lung nodules which, in a small number of patients, may indicate ...
Cancer
5 hours ago |
not rated yet |
0
Poliovirus vaccine trial shows early promise for recurrent glioblastoma
An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.
Cancer
7 hours ago |
not rated yet |
0
If you can remember it, you can remember it wrong
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
B vitamins could delay dementia
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
Reducing caloric intake delays nerve cell loss
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
Antidepressant reduces stress-induced heart condition
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
Insight into the dazzling impact of insulin in cells
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.